Evidence map›Paper›PMID 33539657›Full record

ArticleCytometry. Part B, Clinical cytometry2021

Validation of inducible basophil biomarkers: Time, temperature and transportation.

Theodore Kim, Jing Yu, Henry Li, Mark Scarupa, Richard L Wasserman, Athena Economides, Martha White, Carla Ward, Atul Shah, Douglas Jones and 21 more

Abstract read
In one paragraph

Article in Cytometry. Part B, Clinical cytometry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Basophil activation test in food allergy: is it ready for real-time?Current opinion in allergy and clinical immunology · 2021
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Theodore KimAllergy Partners of Northern Virginia, Chantilly, Virginia, USA.ORCID 0000-0001-7745-5482
Jing YuInstitute for Asthma and Allergy, Wheaton, Maryland, SA.
Henry LiInstitute for Asthma and Allergy, Wheaton, Maryland, SA.ORCID 0000-0001-5587-968X
Mark ScarupaInstitute for Asthma and Allergy, Wheaton, Maryland, SA.
Richard L WassermanAllergy Partners of North Texas, Dallas, Texas, USA.ORCID 0000-0002-3447-4859
Athena EconomidesInstitute for Asthma and Allergy, Wheaton, Maryland, SA.ORCID 0000-0003-2340-6364
Martha WhiteInstitute for Asthma and Allergy, Wheaton, Maryland, SA.
Carla WardInstitute for Asthma and Allergy, Wheaton, Maryland, SA.
Atul ShahNew York Food Allergy and Wellness Center, Centereach, New York, USA.ORCID 0000-0001-5324-0882
Douglas JonesTanner Clinic, Layton, Utah, USA.
Melinda RathkopfAllergy Asthma and Immunology Center of Alaska, Anchorage, Alaska, USA.ORCID 0000-0003-1009-5173
Kelly FryeAmerimmune, Fairfax, Virginia, USA.ORCID 0000-0003-2405-0339
Ahmet AybarAnnapolis Pediatric Gastroenterology and Nutrition, Annapolis, Maryland, USA.
Shahrooz ShayeganAllergy Partners of Northern Virginia, Chantilly, Virginia, USA.
Benjamin EnavPediatric Gastroenterology of Northern Virginia, Fairfax, Virginia, USA.ORCID 0000-0003-4061-734X
Laura IspasAllergy, Asthma and Immunology Institute, Leesburg, Virginia, USA.
Denise LoizouAmerimmune, Fairfax, Virginia, USA.
David FitzhughAllergy Partners of Chapel Hill, Chapel Hill, North Carolina, USA.
James TracyAllergy, Asthma and Immunology Associates, Omaha, Nebraska, USA.
James FriedlanderAllergy, Asthma and Immunology Associates, Omaha, Nebraska, USA.
Zachary JacobsThe Center for Allergy and Immunology, Kansas City, Missouri, USA.
Jonathan MatzAllergy and Asthma Specialists of Maryland, Baltimore, Maryland, USA.ORCID 0000-0002-3242-7979
David GoldenAllergy and Asthma Specialists of Maryland, Baltimore, Maryland, USA.ORCID 0000-0001-7596-3707
Donald McNeilOptiMed, Columbus, Ohio, USA.
William McCannAllergy Partners of Western North Carolina, Asheville, North Carolina, USA.
Christopher CopenhaverAllergy Partners of Western North Carolina, Asheville, North Carolina, USA.
Jeffrey FactorNew England Food Allergy Treatment Center, Farmington, Connecticut, USA.
Raavi GuptaAmerimmune, Fairfax, Virginia, USA.ORCID 0000-0003-4647-0553
Oral AlpanAmerimmune, Fairfax, Virginia, USA.ORCID 0000-0001-7467-8541
Matthew PlassmeyerAmerimmune, Fairfax, Virginia, USA.ORCID 0000-0001-8068-2125
Søren Ulrik SønderAmerimmune, Fairfax, Virginia, USA.ORCID 0000-0002-4697-8421

Funding

The study was funded through internal funding.
6 · The paper itself

Abstract

backgroundThe short stability window of several hours from blood collection to measuring basophil activation has limited the use of flow cytometry-based basophil activation assays in clinical settings. We examine if it is possible to extend this window to 1 day allowing for shipment of samples between laboratories. Several options exist for reporting the results including reporting all the measured values directly, calculating ratios and reporting a single value covering all measured results. Each of these options have different stability and value to the physician.

methodsWhole blood samples from peanut allergic patients were stimulated with four different peanut concentrations at Day 0, Day 1, and Day 2. Samples were stored under temperature-controlled conditions. Flow cytometry was used to analyze the samples. The basophil activation and degranulation were measured as percentage of positive CD63 basophils and CD203c MFI fold change. Shipped samples were transported under ambient conditions.

resultsThe results show that CD63 is a stable marker at Day 1. The CD203c ratio decreases significantly at Day 1. Calculating the CD63/IgE ratio proves to be more stable than CD63 alone. The most stable readouts are the semi-quantitative results and the trajectory of the dose response curve. Finally, we confirmed that the stability can be extended to samples shipped overnight to the laboratory.

conclusionsIt is possible to extend the stability of the basophil activation assay to 1 day for samples stored at 18-25°C as well as samples shipped under ambient conditions as long as the temperature is within the 2-37°C range.

Indexed as

BasophilsBiomarkersFlow CytometryHumansTemperatureTetraspanin 30BiomarkersTetraspanin 30allergybasophil activation testbasophilsCD63peanut allergy

Identifiers

PMID33539657
PMCPMC9291082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.